PharmAthene, Inc. (PIP) Scheduled to Post Quarterly Earnings on Thursday
PharmAthene, Inc. (NYSE PIP) opened at 0.65 on Wednesday. The company’s 50-day moving average is $0.77 and its 200 day moving average is $2.08. PharmAthene, Inc. has a one year low of $0.47 and a one year high of $3.50.
TRADEMARK VIOLATION WARNING: “PharmAthene, Inc. (PIP) Scheduled to Post Quarterly Earnings on Thursday” was first reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The original version of this piece of content can be accessed at https://theolympiareport.com/2017/11/01/pharmathene-inc-pip-scheduled-to-post-quarterly-earnings-on-thursday.html.
Pharmathene, Inc (Pharmathene) is a biodefense company. The Company is focused on the development of medical counter measures against biological and chemical threats. The Company is involved in the development of two next generation anthrax vaccines. The Company’s anthrax vaccines use recombinant protective antigen (rPA) manufacturing processes.
Receive News & Ratings for PharmAthene Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmAthene Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.